Literature DB >> 15497213

Bacterial translocation in experimental uremia.

Joãn Bosco de Almeida Duarte1, José Eduardo de Aguilar-Nascimento, Mariana Nascimento, Rubens Jardim Nochi.   

Abstract

The aim of this study was to investigate whether or not experimental uremia would induce bacterial translocation. Forty male Wistar rats were randomized into two groups: uremic (n = 20) and control (n = 20). Under anesthesia, the upper and lower left renal poles and the marginal lateral parenchyma were excised in uremic group. Seven days later, in a second operation, the liver, spleen and the mesenteric lymph nodes (MLN) were excised and cultured. Blood samples were sent for biochemical analysis (BUN, creatinine, sodium and potassium) and cultured. Specimens of the jejunum (1 cm below the Treitz angle) and ileum (1 cm above the ileocecal valve) were collected and sent for histological examination and scored for the degree of inflammation of the mucosa using a classification proposed by Chiu et al. in 1970. Uremic rats presented higher BUN, creatinine and potassium than controls. Bacterial translocation was more frequent in uremic than in control animals (8/20 (40%) vs. 1/20 (5%); p = 0.02). Translocation in uremic rats was observed mainly at the MLN (all eight cases). Both at the jejunum (uremic = 3 [0-5] vs. control = 2 [0-4]; p = 0.04) and the ileum (uremic - 2 [0-5] vs. control = 0 [0-3]; p = 0.01), inflammation score was higher in uremic rats than in controls. The intestinal mucosa barrier is impaired and bacterial translocation occurs in experimental uremia. Copyright 2003 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15497213     DOI: 10.1007/s00240-003-0381-7

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  33 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Gut microbial translocation in the pathogenesis of systemic inflammation in patients with end-stage renal disease.

Authors:  Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-09       Impact factor: 3.199

Review 3.  Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.

Authors:  Wei Pan; Yongbo Kang
Journal:  Int Urol Nephrol       Date:  2017-08-28       Impact factor: 2.370

4.  Measurement of the intestinal permeability in chronic kidney disease.

Authors:  Matty L Terpstra; Ramandeep Singh; Suzanne E Geerlings; Frederike J Bemelman
Journal:  World J Nephrol       Date:  2016-07-06

Review 5.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

Review 6.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

Review 7.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

8.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

Authors:  Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121

9.  Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption.

Authors:  Nosratola D Vaziri; Jun Yuan; Mahyar Khazaeli; Yuichi Masuda; Hirohito Ichii; Shuman Liu
Journal:  Am J Nephrol       Date:  2013-05-15       Impact factor: 3.754

Review 10.  The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.

Authors:  Tao Yang; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Nat Rev Nephrol       Date:  2018-07       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.